DiaMedica Therapeutics Inc. (DMAC) Capital expenditures 2017–2025
DiaMedica Therapeutics Inc. (DMAC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$40,000FY2025 · since FY2017: $22,000 → $40,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $40,000 | +60.0% |
| FY2024 | $25,000 | +4.2% |
| FY2023 | $24,000 | -70.4% |
| FY2022 | $81,000 | +268.2% |
| FY2021 | $22,000 | -53.2% |
| FY2020 | $47,000 | +2250.0% |
| FY2019 | $2,000 | -96.0% |
| FY2018 | $50,000 | +127.3% |
| FY2017 | $22,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice